AIM
AZN icon

Artemis Investment Management’s AstraZeneca AZN Stock Holding History

Artemis Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$190M Sell
1,165,929
-113,340
-9% -$18.9M 1.66% 7
2026
Q2 		$239M Sell
1,279,269
-165,296
-11% -$31.1M 2.13% 5
2026
Q1 		$281M Buy
+1,444,565
New +$279M 2.98% 1

Other funds holding AZN

PAS
Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
PNC
Park National Corp Newark, Ohio $3.69B AUM 18.32% 1-Year Est. Return
CCM
Cox Capital Management Andover, Massachusetts $179M AUM 28.94% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CNBT
Canandaigua National Bank & Trust Canandaigua, New York $1.15B AUM
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Artemis Investment Management's AZN Position: Q3 2026 in Review

Artemis Investment Management reduced its AstraZeneca (AZN) stake by 8.9% in Q3 2026, selling an estimated $18.9M and leaving 1,165,929 shares worth $190M. The position accounts for 1.66% of the portfolio, ranked #7.

Artemis Investment Management first reported a position in AZN in Q1 2026 and has held it in 3 quarters since. The position peaked at $281M in Q1 2026. 47 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Artemis Investment Management held 1,165,929 shares of AstraZeneca worth $190M as of Q3 2026.
  • Artemis Investment Management sold 113,340 AstraZeneca shares in Q3 2026, an estimated $18.9M.
  • AstraZeneca made up 1.66% of Artemis Investment Management's portfolio in Q3 2026, its #7 holding.
  • Artemis Investment Management first reported a position in AstraZeneca in Q1 2026 and has held it in 3 quarters since.
  • Artemis Investment Management's AstraZeneca position peaked at $281M in Q1 2026.
  • 47 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Artemis Investment Management's 13F filing for Q3 2026, filed 8 Oct 2026.